Lymphoma Meeting Materials

The Lymphoma Working Committee provides scientific oversight for studies related to hematopoietic cell transplantation for Hodgkin and non-Hodgkin disease. Studies related to cellular therapy evaluating lymphoma-specific questions or those aiming to compare cellular therapy approaches (e.g. CAR-T vs. autologous transplant) are also entertained in collaboration with the Cellular Immunotherapy for Cancer Working Committee.

Meetings are held annually during the Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR. Anyone with interest or expertise in the focus area is encouraged to attend.

2025

• 2025 Lymphoma Agenda
• 2025 Lymphoma Minutes

2024

• 2024 Lymphoma Agenda
• 2024 Lymphoma Minutes and 2024-2025 Overview Plan

2023

• 2023 Lymphoma Agenda
• 2023 Lymphoma Minutes and 2023-2024 Overview Plan

2022

• 2022 Lymphoma Agenda
• 2022 Lymphoma Minutes and 2022-2023 Overview Plan

2021

• 2021 Lymphoma Status Report
• 2021 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR Combined WC Session Minutes

2020

• 2020 Lymphoma Agenda
• 2020 Lymphoma Minutes and 2020-2021 Overview Plan

2019

• 2019 Lymphoma Agenda
• 2019 Lymphoma Minutes and 2019-2020 Overview Plan

 

The TCT® Trademark belongs to the Cardiovascular Research Foundation. ASTCT, CIBMTR, MCW, NMDP, the 2019, 2020, and 2021 TCT Conferences and materials are NOT affiliated with or sponsored by Cardiovascular Research Foundation.